BLTE(Belite Bio, Inc) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-12 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 500 | $170.41 |
| 2026-11-12 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 500 | $166.82 |
| 2026-11-12 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 500 | $164.68 |
| 2026-11-12 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 500 | $162.04 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 2 | $170.02 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 14 | $169.36 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 12 | $168.21 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 78 | $167.59 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 50 | $166.44 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 120 | $165.49 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 24 | $164.64 |
| 2026-10-01 | Scholl Hendrik Peter | Chief Medical Officer | 公开市场卖出 | 200 | $163.62 |
| 2026-09-08 | Lin Yu-Hsin | Chief Executive Officer | 公开市场卖出 | 2,700 | $198.09 |
| 2026-09-08 | Lin Yu-Hsin | Chief Executive Officer | 公开市场卖出 | 8,752 | $197.36 |
| 2026-09-08 | Lin Yu-Hsin | Chief Executive Officer | 公开市场卖出 | 6,058 | $196.54 |
| 2026-09-08 | Lin Yu-Hsin | Chief Executive Officer | 公开市场卖出 | 6,090 | $195.62 |
| 2026-09-08 | Lin Yu-Hsin | Chief Executive Officer | 公开市场卖出 | 2,400 | $194.33 |
| 2026-09-08 | Chuang Hao-Yuan | Chief Financial Officer | 公开市场卖出 | 2,562 | $198.05 |
| 2026-09-08 | Chuang Hao-Yuan | Chief Financial Officer | 公开市场卖出 | 4,605 | $197.23 |
| 2026-09-08 | Chuang Hao-Yuan | Chief Financial Officer | 公开市场卖出 | 4,475 | $196.47 |